Antineo
Antineo is a contract research organization providing services in preclinical therapeutic research in oncology. We offer services to customers wishing to evaluate the safety, tolerability and the antitumor activity of their compounds in the most relevant models, either as single agents or in combination with standard therapies, as well as in models resistant to conventional treatment. Our services include personalized advice and dedicated expertise to determine the most relevant models and to optimize the preclinical strategy for your future clinical development. Our services are provided by a team with international level expertise in onco-pharmacology.
